Pyrimethamine for Primary Prophylaxis of Toxoplasmic Encephalitis in Patients with Human Immunodeficiency Virus Infection: A Double-Blind, Randomized Trial
Authors:
- Geneviève Ch⩽NeGCGeneviève Ch⩽Ne
- Philippe MorlatPMPhilippe Morlat
- Benjamin J. LuftBLBenjamin J. Luft
- Franck RousseauFRFranck Rousseau
- Sophie PueyoSPSophie Pueyo
- Richard HafnerRHRichard Hafner
- Jose MiroJMJose Miro
- Jean AubertinJAJean Aubertin
- Roger SalamonRSRoger Salamon
- Jean-Louis VildéJVJean-Louis Vildé
Open Access
- 1 January 1996
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 173 (1) , 91-97
Abstract
Pyrimethamine (50 mg) with folinic acid (15 mg) given three times weekly was assessed as primary prophylaxis for toxoplasmic encephalitis (TE) in 554 human immunodeficiency virus-infected patients seropositive for Toxoplasma gondii and with 3. At 1 year, the incidence of TE was similar in pyrimethamine, 12%, and placebo, 13%, groups (relative risk [RR], 0.9; 95% confidence interval [CI], 0.6–1.4), and the survival rate was also similar, 85% and 80%, respectively (RR, 0.9; 95% CI, 0.7–1.2). Rash was the only adverse event that appeared significantly more frequently in the pyrimethamine arm (7% vs. 1%). In the on-treatment analysis, the incidence of TE was lower in the pyrimethamine arm, 4%, than in the placebo arm, 12% (P < .006). Thus, pyrimethamine cannot be recommended as a first-line regimen for primary prophylaxis of TE if the patient can take cotrimoxazole. However, it should be considered for patients who are intolerant to cotrimoxazole, especially in high-risk patients with 3.Keywords
This publication has 15 references indexed in Scilit:
- Lower Survival in AIDS Patients Receiving Dapsone Compared with Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii PneumoniaThe Journal of Infectious Diseases, 1995
- Pyrimethamine as Primary Prophylaxis of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeficiency Virus: Open StudyClinical Infectious Diseases, 1994
- Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV InfectionNew England Journal of Medicine, 1993
- A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992
- A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Prophylaxis for Toxoplasmosis in AIDSAnnals of Internal Medicine, 1992
- Pyrimethamine Concentrations in Serum and Cerebrospinal Fluid During Treatment of Acute Toxoplasma Encephalitis in Patients with AIDSThe Journal of Infectious Diseases, 1988
- COMPLICATIONS OF CO-TRIMOXAZOLE IN TREATMENT OF AIDS-ASSOCIATED PNEUMOCYSTIS CARINII PNEUMONIA IN HOMOSEXUAL MENThe Lancet, 1983
- A Comparative Study of Some Combined Treatment Regimens in Acute Toxoplasmosis in MiceThe American Journal of Tropical Medicine and Hygiene, 1978